Introduction
Parathyroid hormone-related protein (PTHrP) is produced by normal cells and functions locally in diverse tissues, undergoing proteolytic processing into several smaller bioactive forms. PTHrP may regulate cell differentiation or act to signal epithelial-mesenchymal interactions, functioning as a local autocrine/paracrine polyhormone (Rabbani, 2000; Strewler, 2000) . PTHrP also has complex growth-regulatory effects, which can be either inhibitory or stimulatory, and is the causative agent of the paraneoplastic syndrome hypercalcemia (Rabbani, 2000; Strewler, 2000) .
We previously showed that a single-nucleotide polymorphism (SNP) in the C-terminal domain of the mouse parathyroid hormone-like hormone gene (Pthlh) causes an amino-acid variation resulting in two alleles: Pthlh Pro and Pthlh
Thr
. The polymorphism is located at amino acid 166 (precursor protein) or 130 (mature protein), in the C-terminus cleavage polypeptide PTHrP (107-139) (Manenti et al., 2000; Strewler, 2000) . These alleles are linked with high (Pthlh Pro ) and low (Pthlh Thr ) genetic susceptibility to skin tumorigenesis in phenotypically selected Car-S and Car-R mouse lines (Manenti et al., 2000) . A human squamous cell carcinoma (SQCC) cell line transfected with the Pthlh Pro allele displays morphologic changes in vitro that result in island-like colonies with piled-up cells, whereas the nontransfected parental line shows a flattened pattern of colony growth (Manenti et al., 2000) . Moreover, the Pthlh Pro transfectants show an accelerated growth rate in nude mice, whereas Pthlh
Thr allele transfectants show a slightly reduced growth rate, as compared with the nontransfected cells (Manenti et al., 2000) .
In the present study, we examined coding polymorphisms of the Pthlh gene carried by a evolutionarily distant mouse strain (Mus spretus) and performed in vitro assays of cell adhesion, cell migration, and invasion activity of NCI-H520 cells transfected with the Pthlh alleles.
Results
Identification of an M. spretus amino-acid variant of Pthlh Nucleotide sequence analysis of the Pthlh allele carried by the M. spretus SPRET/Ei strain revealed a Thr residue at the previously described Thr166Pro polymorphism (GenBank Accession # AY183377). However, the SPRET/Ei Pthlh allele showed additional nucleotide variations leading to three amino-acid changes in the C-terminus of the PTHrP protein: Ser152, Asp157, and Tyr158, as compared to Ala152, Glu157, Asp158 carried by the BALB/c strain (Accession # NM_008970). All three polymorphisms are conservative, since the Ser152Ala change involves two very small amino acids, although Ser is more polar than Ala; the Asp157Glu change involves two charged residues that are structurally very similar, and the Tyr158Asp variation involves two charged amino acids.
The full-length SPRET/Ei Pthlh allele (Pthlh SerAspTyr ) was cloned into a mammalian expression vector and transfected into NCI-H520 SQCC cells. Three stable transfectants expressing the SPRET/Ei-derived PTHrP protein were studied further (Figure 1, lanes 1-3) . These transfectants showed an island pattern of cell growth in vitro, without piling up (not shown).
Nude mice injected subcutaneously with transfectant cells expressing the SPRET/Ei Pthlh allele (Pthlh SerAspTyr ) developed tumors in 44/110 (40%) injection sites, as compared to 17/20 (85%) tumor incidence in mice injected with vector-transfected cells (Po0.001). For all tumors that grew in the mice, those induced by the Pthlh SerAspTyr transfectants grew at a slightly slower rate than tumors carrying the cloning vector alone, and at the end of the experiment (10 weeks after injection), tumor volumes were 1.6-fold greater in the vectortransfected group (Figure 2 ).
Allele-dependent adhesion of Pthlh-transfected cells
No significant difference between type I collagen and Matrigel in sustaining adhesion was observed for nontransfected, vector-transfected, or any Pthlh-transfected NCI-H520 cells (Figure 3a (Figure 3a) .The difference with respect to the parental cells was most marked for Pthlh Pro transfectants, which showed 1.5 lower adhesion levels as compared to the parental cells (Figure 3a) . Similar findings were observed on collagen type I, with parental and Pthlh Thr transfectants showing very similar levels ( Figure 3a ).
Pthlh
pro allele stimulates cell migration
The NCI-H520 wild-type cells showed a detectable migration after incubation in Boyden chambers for 14 h, and the distinct clones tested showed differences in migration when incubated under the same conditions. In the presence of serum-free medium (SFM), none of the different clones showed any migratory response, suggesting that none of the tested Pthlh alleles was able to induce random migration per se. When incubated in the presence of NIH-3T3-conditioned medium, parental Pro -transfected cells showed their typical appearance of small islands with piled-up cells (not shown).
Discussion
In previous studies, we identified the mouse Pthlh gene as a candidate skin cancer modifier gene, with allelespecific linkage disequilibrium associated with genetic susceptibility and resistance to skin carcinogenesis in noninbred, phenotypically selected Car-S and Car-R mouse lines (Manenti et al., 2000) . When transfected into a human SQCC cell line, the Pthlh Pro allele, linked with susceptibility to tumorigenesis, produced morphological changes in vitro and stimulation of tumor growth rate in vivo (Manenti et al., 2000) . Thus, the Pthlh Pro allele may act as a susceptibility allele in skin tumorigenesis by favoring papilloma growth.
The nucleotide sequence of SPRET/Ei Pthlh allele revealed three newly identified SNPs, which led to three amino-acid changes in the C-terminus of the PTHrP: Ser152Ala, Asp157Glu, and Tyr158Asp, giving rise to a SPRET/Ei allele (Pthlh SerAspTyr ). The three amino-acid changes are conservative, suggesting that the functional activity of the PTHrP protein remains largely intact. The human PTHrP, as compared to its mouse counterpart, shows very high homology in the N-terminal and central regions (aa 1-147) but poor conservation in the C-terminus. The Ser152Ala and Asp157Glu variations correspond to different amino acids in the human PTHrP sequence (Accession # NP_002811), that is, Gly152 and Gly159, respectively, whereas the mouse Tyr158Asp variation may correspond to the human Asp160 residue, with divergence of the SPRET/Ei sequence as compared to the human and laboratory inbred mouse sequences, which carry an Asp residue at this position. At the Thr166Pro polymorphism, the SPRET/Ei strain carried the Thr allele, which is associated with genetic resistance to skin tumorigenesis and with a slightly reduced in vivo growth rate of transfected tumor cells (Manenti et al., 2000) . Pthlh SerAspTyr -transfected NCI-H520 tumor cells grew at a slightly slower rate than vector-transfected cells in nude mice, arguing against any significant role for SPRET/Eispecific polymorphisms in stimulating tumor cell growth.
The Pthlh gene maps in the same chromosomal region as an M. spretus-derived skin cancer modifier locus (Skts12) that affects survival of tumor-bearing mice (Nagase et al., 1999) . The present report, however, was not aimed to test Pthlh candidacy for Skts12, since we studied an inbred M. spretus strain (SPRET/Ei) different from the outbred M. spretus strain used to map the Skts12 locus (Nagase et al., 1999) .
The modulation of susceptibility to skin tumorigenesis and of the growth rate of transfected tumor cells by the Pthlh alleles may be due to several mechanisms. Tumor development is a complex phenomenon and involves several tumor-host interactions, including those that determine cell migration, adhesion, and invasion (Cavallaro and Christofori, 2001; Kassis et al., 2001; Pupa et al., 2002) . Our analysis of these parameters in Pthlh-transfected human SQCC NCI-H520 cells revealed a high adhesion capability for the parental and Pthlh-transfected cells, except for the Pthlh Pro allele transfectants, which displayed a 1.5-fold lower adhesion activity with respect to the parental cells. The similar adhesion capability of NCI-H520 cells on two different matrices indicates that adhesion of these cells is mediated by multiple types of integrins. Reported interactions between PTHrP and extracellular matrix include regulation of collagen synthesis by PTHrP in chondrocytes, and extracellular matrix modulation of PTHrP promoter usage, mRNA splicing patterns, and extent of extracellular release (Luparello et al., 1999; Goomer et al., 2000) . A recent study showed that the increased production of PTHrP in stable transfectants of a human colon cancer cell line significantly enhanced cell adhesion to type I collagen, raising the possibility that PTHrP is involved in colon tumor invasion and metastasis (Ye et al., 2001) .
The number of migrating Pthlh Pro -transfected cells was 5-6-fold higher as compared to parental, Pthlh Thr -, and Pthlh SerAspTyr -transfected cells in vitro. Cell motility is under a complex control, mediated by several signaling pathways such as those involving platelet-activating factor, integrins, phosphatidylinositol 3-kinase, and b-catenin (Boccellino et al., 2000; Mercurio et al., 2001; Muller et al., 2002) . PTHrP has been recently shown to inhibit endothelial cell migration in vitro and angiogenesis in vivo by activating endothelial cell protein kinase A (Bakre et al., 2002) . However, opposite effects have been reported in malignant pituitary tumors, in which PTHrP enhances angiogenesis through capillary tube formation by endothelial cells (Akino et al., 2000) . Thus, PTHrP itself might regulate cell-matrix interactions but might also be regulated by the matrix, resulting in the migration of endothelial cells and angiogenesis, or in the effects on migration of cancer cells reported here. An insight into the mechanism of PTHrP-mediated cell migration awaits identification of the specific targets of PTHrP variants and of the biochemical pathways affected by these variants.
Matrix metalloproteases (MMPs), in particular MMP-2 and -9, appear to be key mediators of the matrix degradation required for invasion. While most tumor cells of sarcoma origin secrete high levels of these enzymes, several studies suggest that epithelial tumors do not produce high levels of MMPs themselves (Fassina et al., 1996) , but instead bind and 'use' the MMP-2 released by the tumor stroma. In this context, the inability by NCI-H520 cells to invade Matrigel in vitro may not reflect their invasion potential in vivo.
Since Pthlh has paracrine/autocrine as well as intracrine actions (Strewler, 2000; de Miguel et al., 2001) , we tested whether its tumor modifier effects might be due to the action of secreted PTHrP on surrounding cells. However, despite our previous demonstration that the Pthlh Pro allele induces a clear morphological change in transfected NCI-H520 cells (Manenti et al., 2000) , parental cells cocultured with Pthlh Pro -transfected NCI-H520 cells in Transwell units displayed no morphological alteration. Thus, the morphological changes exerted by the Pro allele are likely due to an intracrine pathway, possibly the same as that mediated by the nuclear localization signal and C-terminus responsible for the mitogenic effects of PTHrP (de Miguel et al., 2001; Tovar Sepulveda et al., 2002) .
The PTHrP C-terminus has been recently shown to interact with the b-arrestin 1B fragment, supporting a novel role for PTHrP in the b-arrestin/MAPK pathway, perhaps in the modulation of the cellular response to extracellular proliferative signals (Conlan et al., 2002) . Deletion of the C-terminus dramatically reduced proliferation of vascular smooth muscle cells (de Miguel et al., 2001) , consistent with the finding of a role for the Thr166Pro polymorphism, located in the PTHrP Cterminus, in modulating tumor cell growth (Manenti et al., 2000) . Our present data indicate that the stimulation of tumor cell growth in PTHrP variants correlates with low cell adhesion and high cell migration efficiencies.
Materials and methods

Cloning and transfection of the M. spretus Pthlh allele
The M. spretus Pthlh allele was cloned by reverse transcription of lung total RNA from SPRET/Ei mice (The Jackson Laboratory, Bar Harbor, ME, USA), followed by cDNA synthesis, PCR amplification of the full-length coding sequence, and cloning into the pCR3.1 mammalian expression vector (Invitrogen) (Manenti et al., 2000) . NCI-H520 cells (American Type Culture Collection, Rockville, MD, USA) were transfected with 1.5-7.5 mg of linearized DNA of recombinant pCR3.1 expression vector containing the SPRET/Ei Pthlh allele or with the cloning vector alone, using thr Superfect s reagent (Quiagen, Valencia, CA 91355, USA). Transfected clones were selected 2 days after transfection in medium containing 1 mg/ml G418 (gentamycin). The expression of recombinant PTHrP protein was assayed by Western blotting (Manenti et al., 2000) and three positive clones were selected (Figure 1, lanes 1-3) .
Cell lines and in vivo tumor growth assay
Nontransfected, Pthlh Thr -and Pthlh Pro -transfected NCI-H520 cells were prepared using the pCR3.1 expression vector and maintained in culture as described (Manenti et al., 2000) .
Adult male CD1 nude mice (Charles River, Calco, Italy) were injected subcutaneously (s.c.) in the left and right dorsal region with 3 Â 10 6 of either three independent stable transfectant Pthlh SerAspTyr clones or vector-transfected NCI-H520 tumor cells. The tumors were measured once a week with a Vernier caliper, and the tumor volume was calculated as length Â width Â height Â 0.5236.
Adhesion assay
Bacterial culture plates (96-microwell, Nunc) were precoated with 100 ml/well of serum-free medium containing 0.1%. BSA (SFM, negative control), type I collagen (50 mg/ml in 0.1% acetic acid), or Matrigel (50 mg/ml in water). After 1 h, all coating solutions were removed and cell clones were plated (10 000 cells/200 ml/well) in SFM. As an additional control, the same cell suspension was also plated in 96-well plates with complete medium to verify the adhesive properties of the cell clones. After incubation for 2 h at 371C in 5% CO 2 , cells were fixed and stained with a formalin/ethanol/crystal-violet fixing/ staining solution, washed extensively in tap water, air-dried, and the dye was eluted with ethanol/acetic acid solution. The readings were performed at 595 nm. The values were normalized to background adhesion.
Cell migration assay
Conditioned medium from NIH-3T3 cells was prepared and the Boyden chamber chemotaxis assay was carried out as described (Postlethwaite et al., 1976) . Briefly, polycarbonate filters (8-mm pore size, PVP-free from Costar-Nuclepore) were incubated in gelatin solution (5 mg/l) for 1 h at 981C and dried in an oven for 1 h at 981C. NIH-3T3-conditioned medium was used as chemoattractant, while SFM containing 0.1% BSA was used as negative control for random unstimulated migration. Cells were harvested with trypsin, washed with SFM/0.1% BSA, and placed in the upper compartment of the Boyden chamber (1.5-3 Â 10 5 cells/800 ml/chamber). Chambers were incubated at 371C in 5% CO 2 for 6 or 14 h. After incubation, cells remaining on the upper surface of the filter were mechanically removed, and those that migrated to the filter underside were fixed with ethanol, stained with toluidine blue (Sigma) and quantified microscopically. A total of 5-10 random fields (representing 1/160 of the total area) were counted. Assays were performed in triplicate and repeated four times.
Chemoinvasion assay
The chemoinvasion assay was performed as described above for chemotaxis, except that the filters were precoated with Matrigel (8-12 mg/50 ml/filter), which was dried and reconstituted at 371C into an even, solid gel on the filter surface (Albini et al., 1987; Albini, 1998) . ) and of vector-transfected cells was grown on the polycarbonate membrane (0.4-mm pore size) of the Transwells. Cells were microscopically checked for morphological changes up to 12 days after seeding.
Statistical analysis
Tumor incidence was evaluated by the w 2 test. Significant differences between groups were determined using univariate analysis of variance, followed by Scheffe's multiple comparison test (SPSS 10.1, SPSS Inc., Chicago, IL, USA).
Abbreviations MMP, matrix metals protease; Pthlh, parathyroid hormonelike hormone gene; PTHrP, parathyroid hormone-related protein; SNP, single-nucleotide polymorphism; SQCC, squamous cell carcinoma.
